China Pharma (NYSE:CPHI) Now Covered by StockNews.com

StockNews.com began coverage on shares of China Pharma (NYSE:CPHI) in a research note released on Monday morning. The brokerage issued a hold rating on the stock.

China Pharma Stock Down 6.5 %

NYSE CPHI opened at $0.17 on Monday. The firm’s 50 day moving average is $0.22 and its 200-day moving average is $0.23. The company has a current ratio of 0.79, a quick ratio of 0.26 and a debt-to-equity ratio of 0.22. China Pharma has a 12-month low of $0.13 and a 12-month high of $0.69.

China Pharma Company Profile

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.